Abiopharma

News list

Director Feinberg Peter 🟢 acquired 20.0K shares of Immuneering Corp (IMRX) at $4.35 Transaction Date: Jan 12, 2026 | Filing ID: 000008

Full text

News bot Jan. 29, 2026, 2:23 p.m.
🔍 Feinberg Peter (Director)

Company: Immuneering Corp (IMRX)

Report Date: 2026-01-12
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 0
- Holdings reported: 3
- Total shares acquired: 20,000
- Total shares held: 1,025,623
Detailed Transactions and Holdings:
- Acquired 20,000 shares of Class A Common Stock at $4.3452 per share (Direct)
  Date: 2026-01-12 | Code: P | equity_swap_involved: 0 | shares_owned_after: 135,441.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-01-12 | Code: H | shares_owned_after: 156,766.00
- Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-01-12 | Code: H | nature_of_ownership: General Partner of PF Associates L.P. | shares_owned_after: 392,242.00
- Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-01-12 | Code: H | nature_of_ownership: General Partner of PEF LLC. | shares_owned_after: 476,615.00
Footnotes:
- F1: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.315 to $4.38. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.